Natixis’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23
Closed -$1.84K 1187
2025
Q2
$1.84K Hold
23
﹤0.01% 984
2025
Q1
$1.97K Sell
23
-257
-92% -$21.1K ﹤0.01% 922
2024
Q4
$21.9K Buy
280
+33
+13% +$2.56K ﹤0.01% 933
2024
Q3
$17.8K Hold
247
﹤0.01% 831
2024
Q2
$17K Sell
247
-676
-73% -$45.8K ﹤0.01% 826
2024
Q1
$67K Buy
923
+722
+359% +$48.3K ﹤0.01% 806
2023
Q4
$12.3K Sell
201
-302
-60% -$17.9K ﹤0.01% 897
2023
Q3
$28.8K Sell
503
-235
-32% -$14.2K ﹤0.01% 852
2023
Q2
$43.9K Hold
738
﹤0.01% 856
2023
Q1
$46.2K Buy
738
+156
+27% +$9.74K ﹤0.01% 836
2022
Q4
$36.4K Buy
+582
New +$33.4K ﹤0.01% 947
2020
Q4
Sell
-9,500
Closed -$346K 1091
2020
Q3
$346K Buy
+9,500
New +$353K ﹤0.01% 642
2017
Q4
Sell
-10,242
Closed -$513K 1085
2017
Q3
$513K Buy
10,242
+6,215
+154% +$318K ﹤0.01% 672
2017
Q2
$213K Buy
+4,027
New +$216K ﹤0.01% 743

Other funds holding PBH

Natixis's PBH Position: Q3 2025 in Review

Natixis sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 23 shares — an estimated $1.84K sold.

Natixis first reported a position in PBH in Q2 2017 and held it in 14 quarters. The position peaked at $513K in Q3 2017. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Natixis reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 23 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.84K.
  • Natixis first reported a position in Prestige Consumer Healthcare in Q2 2017 and held it in 14 quarters.
  • Natixis's Prestige Consumer Healthcare position peaked at $513K in Q3 2017.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.